| September | | EU |  |
|---|
| | Saudi Arabia |  |
|---|
| | Taiwan DMF |  |
|---|
| August | | Egypt DMF |  |
|---|
| | UK |  |
|---|
| Tirzepatide | Brazil DMF |  |
|---|
| July | | Indonesia |  |
|---|
| Tafamidis (Form-1) | US |  |
|---|
| | Singapore DMF |  |
|---|
| Tafamidis (Form-1) | Brazil DMF |  |
|---|
| | Saudi Arabia |  |
|---|
| | Taiwan DMF |  |
|---|
| June | | Indonesia |  |
|---|
| | Brazil DMF |  |
|---|
| | Canada DMF |  |
|---|
| May | Olutasidenib | Brazil DMF |  |
|---|
| | Saudi Arabia |  |
|---|
| | South Africa |  |
|---|
| Alectinib Hydrochloride | Brazil DMF |  |
|---|
| | Singapore DMF |  |
|---|
| April | | EU |  |
|---|
| | Europe (CEP) |  |
|---|
| | UK |  |
|---|
| March | | US |  |
|---|
| | US |  |
|---|
| | US |  |
|---|
| | US |  |
|---|
| | US |  |
|---|
| Pentosan polysulfate sodium | US |  |
|---|
| | US |  |
|---|
| Tirzepatide | US |  |
|---|
| | Brazil DMF |  |
|---|
| | Japan DMF |  |
|---|
| Atorvastatin Calcium Trihydrate [Form-I] [AFP Process] | Europe (CEP) | ![Atorvastatin Calcium Trihydrate [Form-I] [AFP Process]](/_next/image?url=%2Fimages%2Fhpapi-cont-1.png&w=32&q=75) |
|---|
| | Europe (CEP) |  |
|---|
| | Europe (CEP) | ![Dapagliflozin Propylene Glycol [Process-II]](/_next/image?url=%2Fimages%2Fhpapi-cont-1.png&w=32&q=75) |
|---|
| | Korea DMF |  |
|---|
| | Taiwan DMF |  |
|---|
| | Taiwan DMF |  |
|---|
| February | | Russia DMF |  |
|---|
| | Taiwan DMF |  |
|---|
| | Korea DMF |  |
|---|
| Pazopanib HCl | UK |  |
|---|
| | Korea DMF |  |
|---|
| Deucravacitinib Premix | US |  |
|---|
| | EU |  |
|---|
| January | | Saudi Arabia |  |
|---|
| Fexofenadine HCl | Singapore DMF |  |
|---|
| | CEP DMF Filed |  |
|---|